The $193 Billion US-China War You Don't Know About

From Investing Trends | Ad

They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.

The US-China "Lithium War" Is Creating Opportunity

PRTK Insider Trading (Paratek Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,558,231.64

Paratek Pharmaceuticals Insider Trading History Chart

Paratek Pharmaceuticals Share Price & Price History

^$2.01

▲ +0.05 (2.55%)

As of 05/19/2022 12:35 PM ET

Days: 30 | 90 | 365

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

Paratek Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2021	Evan Loh	CEO	Sell	49,259	$4.27	$210,335.93
12/15/2021	Michael Bigham	Chairman	Sell	17,819	$4.27	$76,087.13
12/15/2021	Randall B. Brenner	Insider	Sell	15,780	$4.27	$67,380.60
12/15/2021	William M Haskel	General Counsel	Sell	17,178	$4.27	$73,350.06
12/13/2021	Evan Loh	CEO	Sell	13,983	$4.42	$61,804.86
12/13/2021	Michael Bigham	Chairman	Sell	5,059	$4.42	$22,360.78
12/13/2021	Randall B. Brenner	Insider	Sell	4,479	$4.42	$19,797.18
12/13/2021	William M Haskel	General Counsel	Sell	4,876	$4.42	$21,551.92
8/17/2021	Evan Loh	CEO	Sell	33,931	$5.12	$173,726.72	1,034,291
8/17/2021	Michael Bigham	Chairman	Sell	32,030	$5.12	$163,993.60	954,312
8/17/2021	Randall B. Brenner	Insider	Sell	8,766	$5.12	$44,881.92	512,296
8/17/2021	William M Haskel	General Counsel	Sell	9,692	$5.12	$49,623.04	380,217
6/4/2021	Adam Woodrow	Insider	Sell	17,182	$9.70	$166,665.40	491,978
6/4/2021	Michael Bigham	Chairman	Sell	34,364	$9.70	$333,330.80	913,676
6/4/2021	William M Haskel	General Counsel	Sell	7,561	$9.70	$73,341.70	364,653
12/14/2020	Adam Woodrow	Insider	Sell	12,855	$6.71	$86,257.05	284,128
12/14/2020	Evan Loh	CEO	Sell	26,415	$6.71	$177,244.65	626,974
12/14/2020	Michael Bigham	Chairman	Sell	26,063	$6.71	$174,882.73	572,580
12/14/2020	William M Haskel	General Counsel	Sell	6,842	$6.71	$45,909.82	210,109
12/11/2020	Adam Woodrow	Insider	Sell	9,045	$6.95	$62,862.75	284,128
12/11/2020	Evan Loh	CEO	Sell	18,585	$6.95	$129,165.75	626,974
12/11/2020	Michael Bigham	Chairman	Sell	18,337	$6.95	$127,442.15	572,580
12/11/2020	William M Haskel	General Counsel	Sell	4,814	$6.95	$33,457.30	210,109
11/13/2020	Evan Loh	CEO	Sell	20,928	$5.93	$124,103.04	666,487
11/13/2020	Michael Bigham	Chairman	Sell	26,250	$5.93	$155,662.50	617,167
11/13/2020	Randall B. Brenner	Insider	Sell	8,357	$5.93	$49,557.01	152,063
11/13/2020	William M Haskel	General Counsel	Sell	6,892	$5.93	$40,869.56	221,815
5/12/2020	Evan Loh	CEO	Sell	9,595	$4.75	$45,576.25	552,008
5/12/2020	Michael Bigham	Chairman	Sell	12,250	$4.68	$57,330.00	542,167
5/12/2020	Randall B. Brenner	Insider	Sell	6,198	$4.75	$29,440.50	130,813
5/12/2020	William M Haskel	VP	Sell	4,666	$4.75	$22,163.50	198,690
12/12/2019	Evan Loh	CEO	Sell	14,514	$3.10	$44,993.40	417,603
12/12/2019	Randall B. Brenner	Insider	Sell	6,278	$3.10	$19,461.80	92,011
12/12/2019	William M Haskel	VP	Sell	2,864	$3.10	$8,878.40	158,356
10/8/2019	Adam Woodrow	Insider	Sell	5,322	$3.82	$20,330.04	217,694
10/8/2019	Evan Loh	CEO	Sell	7,818	$3.82	$29,864.76	439,935
10/3/2019	Evan Loh	CEO	Sell	16,265	$3.98	$64,734.70	413,935
10/3/2019	Randall B. Brenner	Insider	Sell	7,674	$3.98	$30,542.52	91,338

The Incredible Dividend Map... Where Stocks Yield 26% a Year!

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Paratek Pharmaceuticals (NASDAQ:PRTK)

59.46% of Paratek Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Paratek Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2022	BNP Paribas Arbitrage SA	40,924	$0.12M	0.0%	-15.8%	0.075%
5/17/2022	Worth Venture Partners LLC	783,731	$2.33M	1.1%	+40.7%	1.439%
5/17/2022	Rock Springs Capital Management LP	1,726,637	$5.13M	0.1%	+1.7%	3.169%
5/16/2022	Goldman Sachs Group Inc.	259,942	$0.77M	0.0%	+2.2%	0.477%
5/16/2022	State Street Corp	824,540	$2.45M	0.0%	+7.2%	1.514%
5/16/2022	J. Goldman & Co LP	1,056,631	$3.14M	0.1%	N/A	1.940%
5/13/2022	Renaissance Technologies LLC	173,424	$0.52M	0.0%	+349.0%	0.318%
5/13/2022	Northern Trust Corp	449,337	$1.34M	0.0%	-3.7%	0.825%
5/13/2022	Charles Schwab Investment Management Inc.	129,672	$0.39M	0.0%	+5.7%	0.238%
5/13/2022	XTX Topco Ltd	35,324	$0.11M	0.0%	+33.6%	0.065%
5/13/2022	Vanguard Group Inc.	2,278,878	$6.77M	0.0%	+5.4%	4.183%
5/12/2022	BlackRock Inc.	2,940,513	$8.73M	0.0%	-1.2%	5.398%
5/12/2022	Rhumbline Advisers	44,588	$0.13M	0.0%	-14.5%	0.082%
5/12/2022	AIGH Capital Management LLC	3,139,714	$9.33M	2.3%	+34.2%	5.763%
5/12/2022	1492 Capital Management LLC	509,828	$1.51M	0.8%	+3.8%	0.936%
5/11/2022	JPMorgan Chase & Co.	28,946	$86K	0.0%	+28.9%	0.053%
5/11/2022	GSA Capital Partners LLP	79,448	$0.24M	0.0%	+52.0%	0.146%
5/9/2022	CM Management LLC	350,000	$1.04M	0.9%	+16.7%	0.642%
5/9/2022	Principal Financial Group Inc.	33,301	$99K	0.0%	-33.7%	0.061%
5/5/2022	New York State Common Retirement Fund	32,513	$97K	0.0%	-67.0%	0.060%
5/2/2022	General American Investors Co. Inc.	1,448,170	$4.30M	0.4%	+10.8%	2.658%
5/2/2022	National Asset Management Inc.	46,200	$0.14M	0.0%	+33.1%	0.085%
4/20/2022	Perkins Capital Management Inc.	49,700	$0.15M	0.1%	-17.4%	0.095%
3/9/2022	Norges Bank	79,200	$0.36M	0.0%	N/A	0.162%
2/23/2022	Barclays PLC	59,447	$0.27M	0.0%	+204.4%	0.122%
2/23/2022	BlackRock Inc.	2,977,680	$13.37M	0.0%	+2.1%	6.102%
2/19/2022	Wells Fargo & Company MN	232,202	$1.04M	0.0%	-92.4%	0.476%
2/17/2022	Goldman Sachs Group Inc.	254,313	$1.14M	0.0%	-6.7%	0.521%
2/16/2022	The Manufacturers Life Insurance Company	28,236	$0.13M	0.0%	+25.4%	0.058%
2/16/2022	Deutsche Bank AG	31,268	$0.14M	0.0%	-98.4%	0.064%
2/15/2022	Stifel Financial Corp	43,773	$0.20M	0.0%	-61.5%	0.090%
2/15/2022	Cubist Systematic Strategies LLC	12,526	$56K	0.0%	N/A	0.026%
2/15/2022	1492 Capital Management LLC	491,033	$2.21M	1.1%	+0.6%	1.006%
2/14/2022	D. E. Shaw & Co. Inc.	28,413	$0.13M	0.0%	-48.8%	0.058%
2/14/2022	State Street Corp	769,446	$3.46M	0.0%	+1.5%	1.577%
2/14/2022	LPL Financial LLC	89,330	$0.40M	0.0%	-13.7%	0.183%
2/14/2022	Goldman Sachs Group Inc.	254,313	$1.14M	0.0%	-6.7%	0.521%
2/14/2022	Nuveen Asset Management LLC	132,749	$0.56M	0.0%	-12.3%	0.272%
2/14/2022	Barclays PLC	59,447	$0.27M	0.0%	+204.4%	0.122%
2/14/2022	GSA Capital Partners LLP	52,256	$0.24M	0.0%	-34.2%	0.107%
2/14/2022	Omega Fund Management LLC	1,971,241	$8.85M	1.3%	-24.4%	4.040%
2/11/2022	Geode Capital Management LLC	760,816	$3.42M	0.0%	+9.1%	1.559%
2/11/2022	Gamco Investors INC. ET AL	49,000	$0.22M	0.0%	+44.1%	0.100%
2/11/2022	Renaissance Technologies LLC	38,624	$0.17M	0.0%	-80.8%	0.079%
2/11/2022	Charles Schwab Investment Management Inc.	122,653	$0.55M	0.0%	+5.4%	0.251%
2/11/2022	General American Investors Co. Inc.	1,306,919	$5.87M	0.5%	+17.5%	2.678%
2/10/2022	Pictet Asset Management SA	335,044	$1.50M	0.0%	+88.3%	0.687%
2/10/2022	Citigroup Inc.	14,664	$66K	0.0%	+70.7%	0.030%
2/10/2022	Perkins Capital Management Inc.	60,200	$0.27M	0.2%	-21.0%	0.123%
2/10/2022	Campbell & CO Investment Adviser LLC	17,000	$76K	0.0%	N/A	0.035%
2/10/2022	AIGH Capital Management LLC	2,339,107	$10.50M	3.2%	+45.3%	4.794%
2/10/2022	Weil Company Inc.	33,235	$0.15M	0.1%	-37.6%	0.068%
2/9/2022	Principal Financial Group Inc.	50,216	$0.23M	0.0%	-9.8%	0.103%
2/9/2022	BNP Paribas Arbitrage SA	48,624	$0.22M	0.0%	+510.3%	0.100%
2/9/2022	Baird Financial Group Inc.	44,625	$0.20M	0.0%	-11.7%	0.091%
2/8/2022	Bank of America Corp DE	116,120	$0.52M	0.0%	-25.0%	0.238%
2/7/2022	SG Americas Securities LLC	19,274	$87K	0.0%	-39.3%	0.039%
2/2/2022	New York State Common Retirement Fund	98,413	$0.44M	0.0%	-13.0%	0.202%
2/2/2022	CM Management LLC	300,000	$1.35M	1.0%	+50.0%	0.615%
1/28/2022	Allspring Global Investments Holdings LLC	237,131	$1.06M	0.0%	N/A	0.486%
1/28/2022	National Asset Management Inc.	34,700	$0.16M	0.0%	-14.7%	0.071%
11/18/2021	Bank of New York Mellon Corp	140,159	$0.68M	0.0%	+10.0%	0.287%
11/16/2021	BNP Paribas Arbitrage SA	7,967	$39K	0.0%	+378.5%	0.016%
11/16/2021	National Asset Management Inc.	40,700	$0.20M	0.0%	+42.3%	0.083%
11/16/2021	Two Sigma Advisers LP	355,400	$1.73M	0.0%	-31.9%	0.728%
11/16/2021	Two Sigma Investments LP	11,687	$57K	0.0%	-93.0%	0.024%
11/16/2021	Telemetry Investments L.L.C.	242,514	$1.18M	1.6%	+44.8%	0.497%
11/16/2021	LPL Financial LLC	103,480	$0.50M	0.0%	+11.6%	0.212%
11/16/2021	Millennium Management LLC	22,313	$0.11M	0.0%	-91.1%	0.046%
11/15/2021	California State Teachers Retirement System	24,640	$0.12M	0.0%	-61.0%	0.050%
11/15/2021	Rock Springs Capital Management LP	1,665,014	$8.09M	0.2%	+0.6%	3.412%
11/15/2021	Marshall Wace LLP	111,547	$0.54M	0.0%	-55.7%	0.229%
11/15/2021	Morgan Stanley	163,833	$0.80M	0.0%	+9.5%	0.336%
11/15/2021	Invesco Ltd.	18,484	$90K	0.0%	+27.2%	0.038%
11/15/2021	HighVista Strategies LLC	19,182	$93K	0.1%	N/A	0.039%
11/15/2021	Granahan Investment Management Inc. MA	821,654	$3.99M	0.1%	-1.5%	1.684%
11/15/2021	GSA Capital Partners LLP	79,436	$0.39M	0.0%	+360.7%	0.163%
11/12/2021	Trexquant Investment LP	32,867	$0.16M	0.0%	N/A	0.067%
11/12/2021	Renaissance Technologies LLC	201,624	$0.98M	0.0%	-52.9%	0.413%
11/12/2021	Gamco Investors INC. ET AL	34,000	$0.17M	0.0%	N/A	0.070%
11/12/2021	1492 Capital Management LLC	488,309	$2.37M	1.2%	+284.5%	1.001%
11/12/2021	The Manufacturers Life Insurance Company	22,520	$0.11M	0.0%	-23.6%	0.046%
11/12/2021	Geode Capital Management LLC	697,621	$3.39M	0.0%	-3.7%	1.430%
11/12/2021	AIGH Capital Management LLC	1,609,398	$7.82M	1.6%	+74.4%	3.298%
11/10/2021	Goldman Sachs Group Inc.	272,439	$1.32M	0.0%	+7.0%	0.558%
11/9/2021	Barclays PLC	19,528	$94K	0.0%	+212.1%	0.040%
11/9/2021	BlackRock Inc.	2,917,140	$14.18M	0.0%	+0.7%	5.978%
11/9/2021	Principal Financial Group Inc.	55,658	$0.27M	0.0%	-44.4%	0.114%
11/8/2021	Summit Global Investments	18,600	$90K	0.0%	N/A	0.038%
11/8/2021	CM Management LLC	200,000	$0.97M	0.7%	+14.3%	0.410%
11/5/2021	Advisor Group Holdings Inc.	11,310	$54K	0.0%	-16.2%	0.023%
11/1/2021	General American Investors Co. Inc.	1,112,658	$5.41M	0.5%	+6.9%	2.280%
11/1/2021	SG Americas Securities LLC	31,745	$0.15M	0.0%	N/A	0.065%
10/26/2021	Trellus Management Company LLC	295,000	$1.43M	1.0%	+3.7%	0.605%
10/25/2021	Jaffetilchin Investment Partners LLC	12,675	$62K	0.0%	-50.0%	0.026%
8/25/2021	Marshall Wace LLP	251,598	$1.72M	0.0%	N/A	0.516%
8/23/2021	Morgan Stanley	149,659	$1.02M	0.0%	-36.8%	0.307%
8/17/2021	Walleye Capital LLC	40,718	$0.28M	0.0%	N/A	0.083%
8/17/2021	Walleye Trading LLC	13,573	$93K	0.0%	N/A	0.028%
8/17/2021	Worth Venture Partners LLC	231,372	$1.58M	0.6%	+21.1%	0.474%

Data available starting January 2016

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $2.01

$1.95

$2.01

50 Day Range

MA: $2.60

$1.83

$3.48

52 Week Range

Now: $2.01

$1.79

$11.23

Volume

4,493 shs

Average Volume

558,569 shs

Market Capitalization

$109.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Who are the company insiders with the largest holdings of Paratek Pharmaceuticals?: Paratek Pharmaceuticals' top insider shareholders include:
Evan Loh (CEO)
Michael Bigham (Chairman)
Randall B Brenner (Insider)
Adam Woodrow (Insider)
William M Haskel (General Counsel)
Randall B Brenner (VP)
Learn More about top insider investors at Paratek Pharmaceuticals.
Who are the major institutional investors of Paratek Pharmaceuticals?: Paratek Pharmaceuticals' top institutional investors include:
AIGH Capital Management LLC — 5.76%
BlackRock Inc. — 5.40%
Vanguard Group Inc. — 4.18%
Rock Springs Capital Management LP — 3.17%
General American Investors Co. Inc. — 2.66%
J. Goldman & Co LP — 1.94%
Learn More about top institutional investors of Paratek Pharmaceuticals stock.
Which institutional investors are selling Paratek Pharmaceuticals stock?: During the last quarter, PRTK stock was sold by these institutional investors:
New York State Common Retirement Fund
BlackRock Inc.
Northern Trust Corp
Principal Financial Group Inc.
Perkins Capital Management Inc.
BNP Paribas Arbitrage SA
Rhumbline Advisers
Group One Trading L.P.
In the previous year, company insiders that have sold Paratek Pharmaceuticals company stock include:
Evan Loh (CEO)
Michael Bigham (Chairman)
Randall B Brenner (Insider)
Adam Woodrow (Insider)
William M Haskel (General Counsel)
Randall B Brenner (VP)
Learn More investors selling Paratek Pharmaceuticals stock.
Which institutional investors are buying Paratek Pharmaceuticals stock?: During the last quarter, PRTK stock was acquired by institutional investors including:
J. Goldman & Co LP
AIGH Capital Management LLC
Worth Venture Partners LLC
General American Investors Co. Inc.
Renaissance Technologies LLC
Vanguard Group Inc.
State Street Corp
CM Management LLC

High Arch Potential Stock

From Wealthy Millionaire | Ad

If you're looking for a hot new sector, watch this stock closely.

Click for ticker & full details